Julia V. Reuwsaat
Porto Alegre, RS 91501970, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Acetylation-mediated fluconazole inactivation: A novel antifungal resistance mechanism.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: November 06, 2025
Integrative Transcriptomic and Systems Biology Analyses Identify TCB1 as a Calcium-Responsive Gene in Cryptococcus neoformans.
Journal: Microorganisms
Published: October 29, 2025
SARS-CoV-2 Infection disrupts lower respiratory tract microbiome function and interactions.
Journal: BMC microbiology
Published: September 05, 2025
A cell wall-targeting urease-derived peptide as a potential antifungal agent against Candida species.
Journal: Current research in microbial sciences
Published: June 05, 2025
Comparative microbiome analysis in cystic fibrosis and non-cystic fibrosis bronchiectasis.
Journal: Respiratory research
Published: January 04, 2024
Too much of a good thing: Overproduction of virulence factors impairs cryptococcal pathogenicity.
Journal: Microbial cell (Graz, Austria)
Published: May 13, 2021
New nanotechnological formulation based on amiodarone-loaded lipid core nanocapsules displays anticryptococcal effect.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 22, 2020
A Plumieridine-Rich Fraction From Allamanda polyantha Inhibits Chitinolytic Activity and Exhibits Antifungal Properties Against Cryptococcus neoformans.
Journal: Frontiers in microbiology
Published: February 28, 2020
Participation of Zip3, a ZIP domain-containing protein, in stress response and virulence in Cryptococcus gattii.
Journal: Fungal genetics and biology : FG & B
Published: December 03, 2019
Pharmacological inhibition of pigmentation in Cryptococcus.
Journal: FEMS yeast research
Published: May 08, 2018
Last Updated: 09/26/2026